A RET::GRB2 fusion in pheochromocytoma defies the classic paradigm of RET oncogenic fusions is a research paper published in Cell Reports Medicine (2022). On theSindex it has a DataRank of 0.421. It has been cited 9 times, with 4 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.345
From this paper's citation signal
Citation Network Contribution
0.0755
From 4 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 4 citers.
National Institutes of Health
Grant: P30-CA54174
U.S. Department of Veterans Affairs
Grant: RP190043
NIGMS
Grant: GM114102
National Institutes of Health
Grant: 5R01ES031522-04
Oxidative stress and RNA methylation
National Institutes of Health
Grant: 5I01BX001882-04
Non-coding RNAs at the interface of aberrant NF-kB signals and lymphomagenesis
National Institutes of Health
Grant: 5R01GM140456-03
Mitochondrial 2-hydroxyglutarate dehydrogenases modulate the cellular epitranscriptome
National Institutes of Health
Grant: 5P30CA054174-16
SAN ANTONIO CANCER INSTITUTE
Fields of Study
Keywords